1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1517/17460441.2011.547189" target="_blank" rel="noreferrer noopener">http://doi.org/10.1517/17460441.2011.547189</a>
Pages
109–127
Issue
2
Volume
6
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.
Publisher
An entity responsible for making the resource available
Expert opinion on drug discovery
Date
A point or period of time associated with an event in the lifecycle of the resource
2011
2011-02
Creator
An entity primarily responsible for making the resource
Darvesh Altaf S; Carroll Richard T; Geldenhuys Werner J; Gudelsky Gary A; Klein Jochen; Meshul Charles K; Van der Schyf Cornelis J
Description
An account of the resource
INTRODUCTION: Microdialysis is an important in vivo sampling technique, useful in the assay of extracellular tissue fluid. The technique has both pre-clinical and clinical applications but is most widely used in neuroscience. The in vivo microdialysis technique allows measurement of neurotransmitters such as acetycholine (ACh), the biogenic amines including dopamine (DA), norepinephrine (NE) and serotonin (5-HT), amino acids such as glutamate (Glu) and gamma aminobutyric acid (GABA), as well as the metabolites of the aforementioned neurotransmitters, and neuropeptides in neuronal extracellular fluid in discrete brain regions of laboratory animals such as rodents and non-human primates. AREAS COVERED: In this review we present a brief overview of the principles and procedures related to in vivo microdialysis and detail the use of this technique in the pre-clinical measurement of drugs designed to be used in the treatment of chemical addiction, neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and as well as psychiatric disorders such as attention-deficit/hyperactivity disorder (ADHD) and schizophrenia. This review offers insight into the tremendous utility and versatility of this technique in pursuing neuropharmacological investigations as well its significant potential in rational drug discovery. EXPERT OPINION: In vivo microdialysis is an extremely versatile technique, routinely used in the neuropharmacological investigation of drugs used for the treatment of neurological disorders. This technique has been a boon in the elucidation of the neurochemical profile and mechanism of action of several classes of drugs especially their effects on neurotransmitter systems. The exploitation and development of this technique for drug discovery in the near future will enable investigational new drug candidates to be rapidly moved into the clinical trial stages and to market thus providing new successful therapies for neurological diseases that are currently in demand.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1517/17460441.2011.547189" target="_blank" rel="noreferrer noopener">10.1517/17460441.2011.547189</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2011
Carroll Richard T
Darvesh Altaf S
Department of Pharmaceutical Sciences
Expert opinion on drug discovery
Geldenhuys Werner J
Gudelsky Gary A
Klein Jochen
Meshul Charles K
NEOMED College of Pharmacy
Van der Schyf Cornelis J